Preventing tumour recurrence | Antikankerfonds (NL)
Preventing tumour recurrence icon

Preventing tumour recurrence

For cancer survivors, the fight isn’t always over. Many are concerned about the possibility of recurrence, and living with uncertainty is never easy. Discovering an intervention that can prevent cancer recurrence has the potential to significantly enhance quality of life.

Preventing tumour recurrence

Fighting the main threat: metastasis

Evidence is occasionally discovered supporting various, often simple interventions that improve existing treatment protocols. These additional therapies prevent tumour recurrence and contribute significantly to better outcomes. With 90% of deaths resulting from tumour recurrence and metastasis, primary tumours are not the main threat. While the mechanism of action of several interventions are not yet fully understood, research indicates that their influence on dormant cancer cells and the body’s own cancer-fighting mechanisms are at the core of their potential.

90%
of deaths
due to tumour recurrence

Our trials in this focus area

Trial phase: 
3
Cancer types: 
  • Melanoma
Status: 
Recruiting
Trial phase: 
3
Cancer types: 
  • Digestive cancer
Status: 
Recruiting
Trial phase: 
3
Cancer types: 
  • Breast cancer
Status: 
Completed

Onze focus

  • Drug repurposing

    Drug repurposing, ook bekend als herpositionering/ heroriëntering van geneesmiddelen, is een ontwikkelingsstrategie...
  • Minder vaak voorkomende en zeldzame kankers

    We focussen niet alleen op de ‘big four’ — prostaat-, darm-, borst- en longkanker. We onderzoeken ook nieuwe...
  • Combinatietherapieën

    Het is belangrijk om de effecten van een combinatie van geneesmiddelen te onderzoeken, naast die die zij in hun eentje...
  • Herval voorkomen

    Voor overlevenden van kanker is het gevecht niet altijd over. Velen maken zich zorgen over de mogelijke terugkeer van...

Zoekt u naar funding?